Integra LifeSciences Holdings Corporation (NASDAQ:IART - Get Free Report) shares were down 4.9% during mid-day trading on Friday . The stock traded as low as $14.74 and last traded at $14.63. Approximately 213,085 shares changed hands during trading, a decline of 80% from the average daily volume of 1,047,780 shares. The stock had previously closed at $15.38.
Integra LifeSciences Stock Up 2.0%
The company has a current ratio of 1.23, a quick ratio of 0.73 and a debt-to-equity ratio of 1.18. The firm has a market cap of $1.12 billion, a P/E ratio of 6.31 and a beta of 1.20. The company's 50 day simple moving average is $13.81 and its 200-day simple moving average is $15.17.
Integra LifeSciences (NASDAQ:IART - Get Free Report) last posted its earnings results on Thursday, July 31st. The life sciences company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.02. Integra LifeSciences had a negative net margin of 30.87% and a positive return on equity of 12.15%. The business had revenue of $415.61 million for the quarter, compared to analysts' expectations of $395.06 million. During the same quarter in the prior year, the business earned $0.63 EPS. The business's revenue for the quarter was down .6% compared to the same quarter last year. Integra LifeSciences has set its FY 2025 guidance at 2.190-2.290 EPS. Q3 2025 guidance at 0.400-0.450 EPS. Research analysts forecast that Integra LifeSciences Holdings Corporation will post 2.45 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Integra LifeSciences
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Principal Financial Group Inc. increased its holdings in Integra LifeSciences by 2.5% in the 1st quarter. Principal Financial Group Inc. now owns 433,924 shares of the life sciences company's stock worth $9,542,000 after acquiring an additional 10,492 shares in the last quarter. Wealth Enhancement Advisory Services LLC purchased a new stake in Integra LifeSciences in the 1st quarter worth approximately $251,000. Victory Capital Management Inc. increased its holdings in Integra LifeSciences by 1,067.6% in the 1st quarter. Victory Capital Management Inc. now owns 147,982 shares of the life sciences company's stock worth $3,254,000 after acquiring an additional 135,308 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Integra LifeSciences by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 38,466 shares of the life sciences company's stock worth $872,000 after acquiring an additional 1,437 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in Integra LifeSciences by 3,595.1% during the 1st quarter. GAMMA Investing LLC now owns 23,353 shares of the life sciences company's stock valued at $5,140,000 after buying an additional 22,721 shares in the last quarter. 84.78% of the stock is owned by hedge funds and other institutional investors.
About Integra LifeSciences
(
Get Free Report)
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services.
Featured Articles
Before you consider Integra LifeSciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integra LifeSciences wasn't on the list.
While Integra LifeSciences currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
